SF0426OA6643/072026
13/07/2028
Active ingredient:
Ondansetron 4 mg.
Therapeutic indications:
Indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, prevention and treatment of postoperative nausea and vomiting (PONV).
Dosage form
Solution for injection.
Active ingredient:300 mg Sertaconazole nitrate Therapeutic indications:Indicated for local...
Read More
Active ingredient:Ketorolac Tromethamine 30 mg. Therapeutic indications:Indicated for the...
Read More
Active ingredient:0.5 mg oxymetazoline hydrochloride Therapeutic indications:Indicated in adults,...
Read More
Factory Locations
Quick Links
© 2024 All rights reserved @PHARO PHARMA
Terms and Conditions | Privacy Policy
